QA: Climb Bio Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001768446_2022_Climb_Bio_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss 2': 2, '100060 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 12}}

Graph

Absolute values for 0001768446, Climb Bio Inc

  xvar xval
0 AssetsCurrent 148,252,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 24,989,000
4 LiabilitiesCurrent 6,031,000
5 LiabilitiesNoncurrent 7,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,350,000
9 ResearchAndDevelopmentExpense 22,046,000
10 remainder_Expenses 1,276,000
11 remainder_Revenues 0
12 remainder_NetIncome -11,808,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 173,241,000
1 Liabilities 6,038,000
2 Expenses 35,672,000
3 Revenues 0
4 StockholdersEquity 167,203,000
5 NetIncome -47,480,000
6 ComprehensiveNetIncome -47,480,000
7 BaseVar 113,379,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.54
9 EconomicCapitalRatio 4.06

Edgar->Model Mapping

Feature Distribution